Cytoplasmic HuR status predicts disease-free survival in resected pancreatic cancer
Objectives:We tested cytoplasmic HuR (cHuR) as a predictive marker for response to chemotherapy by examining tumor samples from the international European Study Group of Pancreatic Cancer-3 trial, in which patients with resected pancreatic ductal adenocarcinoma (PDA) received either gemcitabine (GEM
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2018/02/01
|
| In: |
Annals of surgery
Year: 2018, Jahrgang: 267, Heft: 2, Pages: 364-369 |
| ISSN: | 1528-1140 |
| DOI: | 10.1097/SLA.0000000000002088 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1097/SLA.0000000000002088
|
| Verfasserangaben: | Talar Tatarian, Wei Jiang, Benjamin Leiby, Amanda Grigoli, Masaya Jimbo, Nooreen Dabbish, John Neoptolemos, William Greenhalf, Eithne Costello, Paula Ghaneh, Christopher Halloran, Daniel Palmer, Markus Buchler, Charles Yeo, Jordan Winter, Jonathan Brody |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1665028386 | ||
| 003 | DE-627 | ||
| 005 | 20230426130913.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190509s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/SLA.0000000000002088 |2 doi | |
| 035 | |a (DE-627)1665028386 | ||
| 035 | |a (DE-599)KXP1665028386 | ||
| 035 | |a (OCoLC)1341212698 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Tatarian, Talar |d 1958- |e VerfasserIn |0 (DE-588)1185661727 |0 (DE-627)1665028351 |4 aut | |
| 245 | 1 | 0 | |a Cytoplasmic HuR status predicts disease-free survival in resected pancreatic cancer |c Talar Tatarian, Wei Jiang, Benjamin Leiby, Amanda Grigoli, Masaya Jimbo, Nooreen Dabbish, John Neoptolemos, William Greenhalf, Eithne Costello, Paula Ghaneh, Christopher Halloran, Daniel Palmer, Markus Buchler, Charles Yeo, Jordan Winter, Jonathan Brody |
| 264 | 1 | |c 2018/02/01 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.05.2019 | ||
| 520 | |a Objectives:We tested cytoplasmic HuR (cHuR) as a predictive marker for response to chemotherapy by examining tumor samples from the international European Study Group of Pancreatic Cancer-3 trial, in which patients with resected pancreatic ductal adenocarcinoma (PDA) received either gemcitabine (GEM | ||
| 700 | 1 | |a Büchler, Markus W. |d 1955- |e VerfasserIn |0 (DE-588)120893339 |0 (DE-627)080952526 |0 (DE-576)292434146 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of surgery |d [Erscheinungsort nicht ermittelbar] : Lippincott Williams & Wilkins, 1885 |g 267(2018), 2, Seite 364-369 |h Online-Ressource |w (DE-627)313115222 |w (DE-600)2002200-1 |w (DE-576)090881796 |x 1528-1140 |7 nnas |a Cytoplasmic HuR status predicts disease-free survival in resected pancreatic cancer |
| 773 | 1 | 8 | |g volume:267 |g year:2018 |g number:2 |g pages:364-369 |g extent:6 |a Cytoplasmic HuR status predicts disease-free survival in resected pancreatic cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1097/SLA.0000000000002088 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190509 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 120893339 |a Büchler, Markus W. |m 120893339:Büchler, Markus W. |d 910000 |d 910200 |e 910000PB120893339 |e 910200PB120893339 |k 0/910000/ |k 1/910000/910200/ |p 13 | ||
| 999 | |a KXP-PPN1665028386 |e 3472329041 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","family":"Tatarian","given":"Talar","display":"Tatarian, Talar"},{"given":"Markus W.","display":"Büchler, Markus W.","role":"aut","family":"Büchler"}],"note":["Gesehen am 09.05.2019"],"title":[{"title_sort":"Cytoplasmic HuR status predicts disease-free survival in resected pancreatic cancer","title":"Cytoplasmic HuR status predicts disease-free survival in resected pancreatic cancer"}],"id":{"doi":["10.1097/SLA.0000000000002088"],"eki":["1665028386"]},"recId":"1665028386","name":{"displayForm":["Talar Tatarian, Wei Jiang, Benjamin Leiby, Amanda Grigoli, Masaya Jimbo, Nooreen Dabbish, John Neoptolemos, William Greenhalf, Eithne Costello, Paula Ghaneh, Christopher Halloran, Daniel Palmer, Markus Buchler, Charles Yeo, Jordan Winter, Jonathan Brody"]},"physDesc":[{"extent":"6 S."}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018/02/01"}],"language":["eng"],"relHost":[{"title":[{"title":"Annals of surgery","title_sort":"Annals of surgery","subtitle":"a monthly review of surgical science and practice"}],"note":["Gesehen am 26.09.18"],"id":{"issn":["1528-1140"],"eki":["313115222"],"zdb":["2002200-1"]},"recId":"313115222","physDesc":[{"extent":"Online-Ressource"}],"disp":"Cytoplasmic HuR status predicts disease-free survival in resected pancreatic cancerAnnals of surgery","origin":[{"publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1885","dateIssuedDisp":"1885-","publisherPlace":"[Erscheinungsort nicht ermittelbar] ; [Erscheinungsort nicht ermittelbar]"}],"language":["eng"],"pubHistory":["1.1885 -"],"part":{"pages":"364-369","volume":"267","issue":"2","text":"267(2018), 2, Seite 364-369","extent":"6","year":"2018"},"type":{"bibl":"periodical","media":"Online-Ressource"}}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a TATARIANTACYTOPLASMI2018 | ||